CareDx, Inc.Change of Control Agreement • October 29th, 2020 • CareDx, Inc. • Services-medical laboratories
Subject to your execution below, this letter hereby amends that certain Change of Control and Severance Agreement, dated November 26, 2018 (the “Change of Control Agreement”), between you and CareDx, Inc. (the “Company”) by making the following modifications, in each case effective as of and contingent upon your appointment as the Company’s Chief Executive Officer:
EXECUTIVE CHAIR AGREEMENTExecutive Chair Agreement • October 29th, 2020 • CareDx, Inc. • Services-medical laboratories • California
This Executive Chair Agreement (this “Agreement”) is entered into by and between Peter K. Maag, Ph.D. (“Executive”) and CareDx, Inc., a Delaware corporation (the “Company”), effective as of November 1, 2020.
